DNA Vaccine Construct Formation using Mycobacterium-Specific Gene Inh-A | [Abstract Book on Global Science Technology and Management Conference • 2023]

Author(s):

1. Summayya Anwar: Institute of Molecular Biology and Biotechnology, The University of Lahore, Pakistan, Lahore, Pakistan

2. Javed Anver Qureshi: Institute of Molecular Biology and Biotechnology, The University of Lahore, Pakistan, Lahore, Pakistan

3. Mirza Imran Shahzad: Institute of Molecular Biology and Biotechnology, The University of Lahore, Pakistan, Lahore, Pakistan

4. Muhammad Mohsin Zaman: Institute of Molecular Biology and Biotechnology, The University of Lahore, Pakistan, Lahore, Pakistan

5. Aeman Jilani: Institute of Molecular Biology and Biotechnology, The University of Lahore, Pakistan, Lahore, Pakistan

Abstract:

Tuberculosis (TB) remains a highly contagious disease and a leading cause of death worldwide. It is caused by Mycobacterium tuberculosis and Mycobacterium bovis. TB infection is still uncontrolled because of the unavailability of an effective vaccine, co-infection with HIV, lengthy treatment, and the emergence of resistant forms of M. tb like multi/extreme drug resistance strains. TB is mainly a disease of underdeveloped countries because of inadequate health facilities. The development of the new state of modern art vaccine-like DNA vaccine is a promising approach to control TB. The DNA vaccine can be used alone or in combination with Bacille Calmette Guerin (BCG). The objective of the current study is to develop an M. tb gene inh-A based DNA vaccine. The immunodominant gene (Rv1484/INH-A) was amplified using sequence-specific primers. The amplified product was cloned into Topo 2.1 polymerase chain reaction vector, confirmed through restriction digestion and sequence analysis. Finally, subcloned into mammalian expression pVAX1 vector. The inh/A-pVAX1 construct was again confirmed through restriction digestion and sequence analysis. The rightly oriented constructs were selected, and these will be used for in Vivo DNA vaccine immunization studies. DNA vaccine can be used alone or in combination with BCG. DNA vaccines have enough potential to be used with TB treatment and reduce the treatment time in future.

Page(s): 108-108

DOI: DOI not available

Published: Journal: Abstract Book on Global Science Technology and Management Conference, Volume: 0, Issue: 0, Year: 2023

Keywords:

DNA vaccine , Mycobacterium tuberculosis , genetic vectors , inhA gene

References:

References are not available for this document.

Citations

Citations are not available for this document.

Citations

Downloads

Views